![]() |
市场调查报告书
商品编码
1722552
2025 年至 2033 年皮下注射针市场报告(按产品类型、应用、最终用户和地区)Hypodermic Needles Market Report by Product Type, Application, End User, and Region 2025-2033 |
2024 年全球皮下注射针市场规模达 31 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 53 亿美元,2025-2033 年期间的成长率 (CAGR) 为 5.91%。由于慢性病发病率不断上升、疫苗和注射药物需求不断增长、针头技术突破提高了患者的舒适度和安全性,以及世界各地特别是新兴经济体战略医疗保健基础设施的扩张,市场正在经历显着增长。
主要市场驱动因素:注射针市场的成长主要受到需要注射药物的慢性病盛行率上升、疫苗和治疗药物需求增加、技术进步提高针头安全性和患者舒适度以及全球医疗保健基础设施扩大的推动。
主要市场趋势:皮下注射针市场趋势包括采用安全设计的针头以尽量减少针刺伤害、越来越倾向于使用较小规格的针头以减少患者不适,以及出现无针注射系统以实现无痛药物输送。
地理趋势:北美拥有发达的医疗保健体系、严格的安全法规以及最新针头技术的高采用率,因此占据了皮下注射针头市场的最大份额。此外,慢性病数量和医疗支出的增加正推动该地区在全球医药市场中占据领先地位。
竞争格局:皮下注射针产业的一些主要市场参与者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、Niprorum Corporation、Retractable Technologies Inc. (Smiths Medical. Medical.
挑战与机会:皮下注射针市场面临的挑战包括对针头处置和环境影响的日益关注、医护人员的针刺伤害以及严格的监管要求。然而,在创新针头技术的开发、新兴市场的扩张以及旨在满足未满足需求和改善患者护理的研发合作方面仍存在着机会。
新的和先进的医疗程序以及医疗保健的日益普及增加了皮下注射针头市场的需求。例如,美国疾病管制与预防中心 (CDC) 表示,美国每年约进行 160 亿次注射,这表明针头在现代医学中的作用和重要性。除此之外,疫苗接种计划、胰岛素治疗和其他医疗干预措施的增加也增加了对皮下注射针的需求,皮下注射针是这些医疗设备在拯救人们生命方面不可或缺的一部分,从而推动了市场的成长。除了全球人口老化之外,慢性疾病也增加了注射胰岛素等药物的需求,从而不断增加註射器和针头的需求。
糖尿病、癌症等全球慢性病的数量每天都在增加。根据世界卫生组织 (WHO) 的数据,非传染性疾病是世界主要死亡原因,约占所有死亡人数的 60%。因此,需要持续供应皮下注射针或静脉注射针来注射胰岛素和化疗药物等药物。此外,随着慢性病患者管理需求的不断增长导致生产量不断增加,皮下注射针市场正在经历显着增长。此外,生物技术的创新突破带来了更多的注射药物製造,从而增加了对皮下注射针头的需求。
许多国家正在将预算分配给疾病预防和控制措施,例如大规模免疫接种和旨在预防爱滋病毒/爱滋病的措施。例如,联合国永续发展目标针对所有年龄层的人改善健康和保健。作为这些措施的一部分,正在部署以皮下注射针为核心的疫苗接种计划,以满足对这些物品的需求。随着各国政府越来越关注公共卫生议程并分配资源对抗传染病,无针注射器市场将因改善医疗服务获取途径和结果的共同努力而经历长期可持续增长。例如,世界卫生组织(WHO)表示,2020年全球有1.16亿婴儿接种了三剂白喉-破伤风-百日咳(DTP)疫苗,展现了疫苗接种的巨大潜力。此外,美国的行动也为同样的目标做出了贡献。
安全注射针占据大部分市场份额
安全皮下注射针可避免医护人员和病患的针刺伤和感染危险。据美国职业安全与健康管理局 (OSHA) 称,全球每年有数百万医护人员受到针刺伤。这是一个重大问题,主要是因为感染血液传染疾病的风险很高。职业安全与健康管理局 (OSHA) 表示,实施可伸缩/屏蔽针头等安全工程设备有助于扩大这些伤害之间的差距。例如,美国职业安全与健康管理局 (OSHA) 估计,在美国,每年使用安全工程设备可以预防约 3.85 亿起针刺伤。随着实施更安全工作环境的法规开始采用安全皮下注射针头的使用,这种需求可能会增加,这将成为该产品后续市场份额的关键因素。
在药物传递方面,慢性病的增加使得对药物进行正确和准确管理的需求不断增加,这直接导致了皮下注射针市场的需求。生物技术和製药业的进步以及注射剂的发明也进一步提高了这项要求。由于全球大力推行传染病接种,世界各地的疫苗接种计画中针头的使用量增加。新冠疫情凸显了疫苗接种计画在公共卫生中的重要性,从而增加了对皮下注射针头的需求。此外,用于诊断目的的血液采集仍然是医疗机构中最重要的血液采集方法,确保了对皮下注射针头的持续需求。这些应用确保了皮下注射针市场持续发展。
医院和诊所是主要的细分市场
医院和诊所推动了皮下注射针市场的成长,在提供医疗服务方面发挥关键作用。根据美国医院协会 (AHA) 统计,截至 2021 年,美国至少有 6000 家获得许可运营的医院,多年来为数百万患者提供服务。皮下注射针头本身是不可或缺的医疗设备,用于医院和诊所进行的各种治疗和程序,例如接种疫苗、注射、抽血和诊断。由于人口老化和慢性病患者人数不断增加,导致医院和诊所的注射针消耗量大幅增加。此外,政府卫生机构制定的严格的感染控制协议确保了医疗品质并防止了医院和诊所内疾病的传播,从而保证了患者的安全和卓越的医疗效果。
北美引领市场,占据最大的注射针市场份额
该报告还对所有主要区域市场进行了全面的分析,包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。根据报告,北美是最大的皮下注射针区域市场。
北美仍然是皮下注射针市场的主力,因为该地区拥有良好的医疗保健基础设施,医疗保健支出在全国名列前茅,对皮下注射针等医疗设备的需求显着增加。例如,美国医疗保险和医疗补助服务中心(CMS)报告称,2020年美国医疗保健支出达到4.1兆美元,这意味着美国在医疗服务和产品上投入了大量资金。此外,美国食品药物管理局 (FDA) 等机构实施了严格的监管标准,以确保对医疗保健提供者和患者至关重要的皮下注射针的有效性、可靠性和可用性。此外,该地区专注于创新且采用最新医疗保健实践的医疗设备,从而促进了皮下注射针的使用,从而使北美成为全球皮下注射针市场的领导者。
市场研究报告也对市场竞争格局进行了全面的分析。也提供了所有主要公司的详细资料。皮下注射针产业的主要市场参与者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、Nipro Corporation、Retractable Technologies Inc.、Smiths. Inc. Inc.、M.
The global hypodermic needles market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.91% during 2025-2033. The market is experiencing significant growth driven by increasing incidence of chronic diseases, rising demand for vaccinations and injectable medicines, needle breakthrough technologies that enhance comfort and safety for patients, and the expansion strategic healthcare infrastructure all over the world especially in the emerging economies.
Major Market Drivers: The hypodermic needles market growth is significantly driven by the rising prevalence of chronic diseases requiring injectable medications, increasing demand for vaccines and therapeutic drugs, technological advancements enhancing needle safety and patient comfort, and expanding healthcare infrastructure globally.
Key Market Trends: The hypodermic needles market trends include the adoption of safety-engineered needles to minimize needlestick injuries, the growing preference for smaller gauge needles for reduced patient discomfort, and the emergence of needle-free injection systems for painless drug delivery.
Geographical Trends: North America has the largest share of the hypodermic needles market due to its a developed healthcare system, stringent safety regulations and a high adoption rate of the latest needle technologies. Moreover, the increasing numbers of chronic diseases and healthcare expenditure are driving the region to take the lead in the global pharmaceutical market.
Competitive Landscape: Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.), Terumo Corporation, among many others.
Challenges and Opportunities: The hypodermic needles market faces challenges sich as rising concerns regarding needle disposal and environmental impact, needlestick injuries among healthcare workers, and stringent regulatory requirements. However, opportunities exist in the development of innovative needle technologies, expansion into emerging markets, and collaborations for research and development aimed at addressing unmet needs and improving patient care.
New and advanced medical procedures and the rising spread of health care has augmented the hypodermic needles market demand. For instance, the Centers for Disease Control and Prevention (CDC) stated that there are approximately 16 billion injections performed yearly in the United States indicating the role and importance of needles in modern medicine. Apart from this, the increase of vaccination programs, insulin therapy and other medical interventions has escalated the demand for hypodermic needles which show an integral part of these medical equipment in saving people's life, thus propelling the market growth. In addition to aging populations worldwide, chronic diseases have heightened the need of injecting medications such as insulin which constantly increase demand of syringes and needles.
The number of chronic diseases from all over the world like diabetes and cancer is expanding every day. As per the World Health Organization (WHO), non-communicable diseases are the leading the cause of death in the world and these diseases are responsible for about 60% of all deaths. As a result, a constant supply of hypodermic or intravenous needles is required for injecting medications such as insulin and chemo drugs. Furthermore, with the increasing amount of production due to a growing need for chronically ill patient management, the hypodermic needles market is experiencing significant growth. Furthermore, the innovative breakthroughs in biotechnology result in more injectable medication manufacturing, escalating the demand for hypodermic needles escalates.
Many countries are allocating their budgets to disease prevention and control measures, such as mass immunization and measures aimed at preventing HIV/AIDS. For instance, the UNSDGs that targets all ages to improve health and wellness. As part of these initiatives, vaccination programs with hypodermic needles as the central element are being deployed, meeting the need for these items. With governments increasingly focusing on the public health agenda and allocating resources to combat infectious diseases, the needle-free injector market is set to experience a long-term sustainable growth due to such concerted efforts at improving the access to and the outcome of care. For instance, during the year of 2020, the World Health Organization (WHO) indicated that 116 million infants across the globe received three doses of the diphtheria-tetanus-pertussis (DTP) vaccine demonstrating the significant potential of vaccination. Additionally, actions as the USA have contributed to the same cause.
Safety hypodermic needles accounts for the majority of the market share
Safety hypodermic needles can avoid needlestick injury and infection hazards among healthcare staff and patients. As stated by the Occupational Safety and Health Administration (OSHA), millions of healthcare workers around the world are affected by needlestick injuries every year. It is a significant issue mainly because of high-risk of contracting bloodborne diseases. The Occupational Safety and Health Administration (OSHA) indicated that implementing safety-engineered devices like retractable/shielded needles can help to widen the gap between these injuries. For instance, OSHA estimates that about 385 million needlestick injuries can be maybe prevented in the United States every year using safety engineered devices. While regulations enforcing safer working environment are adopting the use of safety hypodermic needles, this is likely going to increase, which will be a key factor in the subsequent market share for that product.
In drug delivery, the rise of chronic diseases has escalated the need to have proper and accurate administration of medication which is directly contributing to hypodermic needles market demand. The progress of biotechnology and pharmaceuticals, and the invention of injectable types add to this high level of requests. There has been a rise in needle usage with vaccine programs worldwide mostly, due to the global push for inoculation against infectious diseases. The COVID-19 pandemic has heightened the significance of vaccination projects in public health prompting an increase of demand for hypodermic needles. Furthermore, blood sampling for diagnostic purposes is still the most important blood collection method in health facilities ensuring the consistent demand for hypodermic needles. These applications ensure the continued development of the hypodermic needles market.
Hospitals and clinics represent the leading market segment
Hospitals and clinics propel the hypodermic needles market growth, having a key role in provision of health services. According to the American Hospital Association (AHA), the country had at least 6000 licensed hospitals operating in 2021, serving millions of patients over the years. Hypodermic needles in their turn are indispensable medical equipment that is used throughout numerous treatments and procedures carried out in hospitals and clinics, such as vaccinations, injections, blood drawings and diagnostics. As a result of aging population and the growing number of people with chronic diseases, the consumption of hypodermic needles in hospitals and clinics leads to the fact that these establishments are gaining hypodermic needles in large amounts. In addition, stringent infection control protocols established by government health agencies ensure quality and prevent the spreading of diseases in hospitals and in the clinics, environment guaranteeing patient safety and excellent healthcare results.
North America leads the market, accounting for the largest hypodermic needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hypodermic needles.
North America remains the force of the hypodermic needles market as the region features a good healthcare infrastructure and the healthcare expenditure among the highest in the country generates a notable demand for medical devices, such as hypodermic needles. For instance, the Centers for Medicare & Medicaid Services (CMS), reported that healthcare expenditure in the United States reached $4.1 trillion in 2020, meaning that the nation has invested vast amount of money in health services and products. Besides, agencies like the Food and Drug Administration (FDA) impose stringent regulatory standards that ensure the effectiveness, reliability, and usability of hypodermic needles which are essential for healthcare providers and patients. Also, the region concentrates on medical devices that are both innovative and uses the latest healthcare practices which in turn boosts the use of hypodermic needles, thus placing North America as a market leader in the global hypodermic needles market.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.